T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.74B |
| 2 |
Charles Schwab
SCHW
|
+$1.49B |
| 3 |
Amazon
AMZN
|
+$1.26B |
| 4 |
Lam Research
LRCX
|
+$1.05B |
| 5 |
Las Vegas Sands
LVS
|
+$1.01B |
Top Sells
| 1 |
Yum! Brands
YUM
|
+$1.31B |
| 2 |
Apple
AAPL
|
+$1.29B |
| 3 |
Tesla
TSLA
|
+$1.27B |
| 4 |
JPMorgan Chase
JPM
|
+$1.06B |
| 5 |
Morgan Stanley
MS
|
+$997M |
Sector Composition
| 1 | Technology | 16.94% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 15.14% |
| 5 | Communication Services | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNTA
1251
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $16.8M | ﹤0.01% |
819,190
+10,192
| +1% | +$208K |
|
1252
Pinnacle West Capital
PNW
$10.5B
| $16.6M | ﹤0.01% |
206,038
-6,888
| -3% | -$555K |
|
1253
Globe Life
GL
$11.5B
| $16.6M | ﹤0.01% |
203,580
+461
| +0.2% | +$37.5K |
|
1254
International Flavors & Fragrances
IFF
$16.8B
| $16.6M | ﹤0.01% |
133,624
-540
| -0.4% | -$66.9K |
|
1255
iShares MSCI India ETF
INDA
$9.38B
| $16.6M | ﹤0.01% |
497,459
+162,459
| +48% | +$5.41M |
|
1256
UDR
UDR
$12.7B
| $16.5M | ﹤0.01% |
439,387
| – | – |
|
1257
LKQ Corp
LKQ
$8.31B
| $16.5M | ﹤0.01% |
516,981
+36
| +0% | +$1.15K |
|
1258
Empire State Realty Trust
ESRT
$1.34B
| $16.4M | ﹤0.01% |
961,560
-14,344
| -1% | -$245K |
|
1259
Avery Dennison
AVY
$12.9B
| $16.4M | ﹤0.01% |
160,847
+2,319
| +1% | +$237K |
|
1260
Magnolia Oil & Gas
MGY
$4.41B
| $16.4M | ﹤0.01% |
+1,509,909
| New | +$16.4M |
|
|
FPRX
1261
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $16.4M | ﹤0.01% |
1,037,941
-96,124
| -8% | -$1.52M |
|
1262
Leidos
LDOS
$23.6B
| $16.3M | ﹤0.01% |
276,322
+16,114
| +6% | +$951K |
|
1263
Diageo
DEO
$56.5B
| $16.3M | ﹤0.01% |
113,123
-6,298
| -5% | -$907K |
|
1264
NETSCOUT
NTCT
$1.8B
| $16.2M | ﹤0.01% |
546,489
+5,981
| +1% | +$178K |
|
1265
EchoStar
SATS
$21.5B
| $16.2M | ﹤0.01% |
449,482
-3,058
| -0.7% | -$110K |
|
1266
Stepan Co
SCL
$1.09B
| $16M | ﹤0.01% |
205,024
+2,114
| +1% | +$165K |
|
|
SFE
1267
DELISTED
Safeguard Scientifics, Inc.
SFE
| $15.8M | ﹤0.01% |
1,235,121
-132,827
| -10% | -$1.7M |
|
1268
Paycom
PAYC
$12.5B
| $15.6M | ﹤0.01% |
157,881
-2
| -0% | -$198 |
|
|
MYOV
1269
DELISTED
Myovant Sciences Ltd.
MYOV
| $15.4M | ﹤0.01% |
674,703
+196,094
| +41% | +$4.48M |
|
1270
Sabre
SABR
$738M
| $15.4M | ﹤0.01% |
625,205
-1,546,995
| -71% | -$38.1M |
|
1271
Western Union
WU
$2.71B
| $15.3M | ﹤0.01% |
754,053
+111
| +0% | +$2.26K |
|
1272
Everest Group
EG
$14.7B
| $15.1M | ﹤0.01% |
65,486
-7,297
| -10% | -$1.68M |
|
1273
AES
AES
$9.17B
| $15M | ﹤0.01% |
1,121,096
| – | – |
|
|
DISCK
1274
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $14.9M | ﹤0.01% |
586,039
+48,540
| +9% | +$1.24M |
|
|
ITCI
1275
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $14.9M | ﹤0.01% |
841,188
-302,452
| -26% | -$5.34M |
|